Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein

An epidemic of pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spreading worldwide. SARS-CoV-2 relies on its spike protein to invade host cells by interacting with the human receptor protein Angiotensin-Converting Enzymes 2 (ACE2). Therefore, designing an antibody...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lin, Wu, Yan, Yao, Sheng, Ge, Huan, Zhu, Ya, Chen, Kun, Chen, Wen-zhang, Zhang, Yi, Zhu, Wei, Wang, Hong-yang, Guo, Yu, Ma, Pei-xiang, Ren, Peng-xuan, Zhang, Xiang-lei, Li, Hui-qiong, Ali, Mohammad A., Xu, Wen-qing, Jiang, Hua-liang, Zhang, Lei-ke, Zhu, Li-li, Ye, Yang, Shang, Wei-juan, Bai, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334341/
https://www.ncbi.nlm.nih.gov/pubmed/34349236
http://dx.doi.org/10.1038/s41401-021-00735-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334341/
https://www.ncbi.nlm.nih.gov/pubmed/34349236
http://dx.doi.org/10.1038/s41401-021-00735-z

Ejemplares similares